Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
The most common adverse effects of tirzepatide are gastrointestinal, including nausea (occurring in 15-30% of patients), diarrhea, vomiting, constipation, and abdominal discomfort
In general, tirzepatide tends to produce: Greater total weight loss over time, particularly in patients with metabolic dysfunction Stronger appetite suppression , including reduced cravings and food noise Faster metabolic response due to dual hormone pathway activation Because tirzepatide influences both appetite regulation and insulin sensitivity, it is often more effective for patients with insulin resistance, blood sugar instability, or stubborn weight that has not responded to diet, exercise, or GLP-1 therapy alone
Building Confidence Practice the motion of drawing and injecting with just water before working with actual medication
As of 2026, retatrutide remains investigational and is only available through clinical trials
